[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# $ctxr

Citius Oncology has announced the U.S. commercial launch of LYMPHIR, a novel cancer immunotherapy for Cutaneous T-Cell Lymphoma (CTCL). This launch follows FDA approval and the securing of a permanent Jcode, marking a significant step in the company's oncology treatment offerings.

### About $ctxr
Citius Oncology is a pharmaceutical company focused on oncology treatments and drug delivery systems.  

### Engagements: XXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$ctxr/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$ctxr/time-series/interactions.tsv)  
Current Value: XXX  
Daily Average: XXXXX  
X Week: XXX -XX%  
X Month: XXXXXX -XX%  
X Months: XXXXXXX +32%  
X Year: XXXXXXXXX -XX%  
1-Year High: XXXXXX on 2025-06-09  
1-Year Low: X on 2025-11-17  

Engagements by network (24h):
X: XXX

  
  
### Mentions: XX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$ctxr/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$ctxr/time-series/posts_active.tsv)  
Current Value: XX  
Daily Average: XX  
X Week: XX -XX%  
X Month: XXX -XX%  
X Months: XXXXX +170%  
X Year: XXXXX +118%  
1-Year High: XXX on 2025-07-03  
1-Year Low: X on 2025-09-14  

Mentions by network (24h):
X: XX

  
  
### Creators: X (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$ctxr/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$ctxr/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning $ctxr in the last XX hours which is no change from in the previous XX hours
Daily Average: XX  
X Week: XX -XX%  
X Month: XX -XX%  
X Months: XXXXX +283%  
X Year: XXXXX +160%  
1-Year High: XXX on 2025-06-28  
1-Year Low: X on 2025-09-14  

The most influential creators that mention $ctxr in the last XX hours

| Creator                                            | Rank | Followers | Posts | Engagements |
| -------                                            | ---- | --------- | ----- | ----------- |
| [@CrweWorld](/creator/twitter/CrweWorld)           | X    | XXXXX     | X     | XX          |
| [@CrusaderStocks](/creator/twitter/CrusaderStocks) | X    | XXXXX     | X     | XX          |

[View More](/list/creators/$ctxr/100)
  
  
### Sentiment: XXX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$ctxr/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$ctxr/time-series/sentiment.tsv)  
Current Value: XXX%  
Daily Average: XX%  
X Week: XXX% no change  
X Month: XXX% no change  
X Months: XXX% +50%  
X Year: XXX% +25%  
1-Year High: XXX% on 2024-12-22  
1-Year Low: XX% on 2025-08-07  

Most Supportive Themes:
- Investment and Trading Advice: (60%) Posts offering trading advice, market analysis, and strategies, often mentioning other stocks.
- Company Expansion and Wellness: (20%) Announcements related to company expansion into new market segments like wellness and performance nutrition.
- General Stock Mentions: (20%) Posts that simply mention the stock alongside a list of other trending tickers.
  
Most Critical Themes:
  

### Top $ctxr Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"$KSCP $CENX $CTXR 📈 Access high-quality investment research and exclusive trading tactics at no cost. 🤝 Connect with traders worldwide and grow smarter together"  
[X Link](https://x.com/slone7777/status/1996282696847458661) [@slone7777](/creator/x/slone7777) 2025-12-03T18:17Z X followers, XXX engagements


"$CBDL With a staggering 1405.46% revenue surge since February 2024 CBDL continues its explosive expansion as Smoking Scholars places another major order in New York's $XXX billion cannabis market. @CBDL_StockOTC @TenAssocLLC @o_otcmprofiler $VEEE $AABB $ABML $ALPP $AMRS $APRN $AQMS $AUMN $AXAS $BCRX $BIMI $BLNK $BRTX $CANO $CBAT $CEI $CLDX $CLVS $CPSH $TLRY $CTXR"  
[X Link](https://x.com/CrusaderStocks/status/1996196194737881252) [@CrusaderStocks](/creator/x/CrusaderStocks) 2025-12-03T12:33Z 4683 followers, XXX engagements


"Citius Oncology Announces U.S. Commercial Launch of LYMPHIR a Novel Cancer Immunotherapy for Cutaneous T-Cell Lymphoma (CTCL) $CTOR $CTXR"  
[X Link](https://x.com/CrweWorld/status/1995616906599182487) [@CrweWorld](/creator/x/CrweWorld) 2025-12-01T22:12Z 2354 followers, XX engagements


"$CTOR $CTXR Citius Oncology Announces U.S. Commercial Launch of LYMPHIR a Novel Cancer Immunotherapy for Cutaneous T-Cell Lymphoma (CTCL) Citius Oncology launched LYMPHIR (denileukin diftitox-cxdl) on Dec X 2025 for adult patients with relapsed or refractory Stage IIII cutaneous Tcell lymphoma (CTCL) after at least one prior systemic therapy. FDA approval was supported by Pivotal Study XXX showing an ORR XXXX% XX% of evaluable patients with reduced skin tumor burden and a median time to response XXX months. LYMPHIR has a permanent Jcode (J9161) effective Apr X 2025 and a Category 2A"  
[X Link](https://x.com/MarcJacksonLA/status/1995583426314010704) [@MarcJacksonLA](/creator/x/MarcJacksonLA) 2025-12-01T19:58Z 7624 followers, XXX engagements